Related Experiment Video
Updated: Sep 12, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Tumour budding in gastric and colorectal cancers: A review
Hao Zhang1, Xianyu Meng2, Dongyun Gou3
1Department of Abdominal Surgery, The Second People's Hospital of Hengshui City, Hengshui City, Hebei Province, China.
Abstract:
Tumour budding (TB), characterized by the presence of individual or small clusters of tumor cells at the infiltrative margins of malignant tumors, represents a critical aspect of tumor metastasis and progression. This review synthesizes current research on TB in gastric and colorectal cancers, focusing on its occurrence, biological characteristics, and clinical significance. We discuss the methodologies used for observing and grading TB, its association with the aggressiveness of digestive tract tumors, and the underlying molecular mechanisms, particularly epithelial-mesenchymal transition. Additionally, we explore potential new therapeutic targets related to TB, such as long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and exosomes. By summarizing these findings, we aim to provide insights into the role of TB in gastric and colorectal cancer progression and guide future research directions.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Cancer
Cancers Originate from Somatic Mutations in a Single Cell

